N-nitrosoanabasine

Modify Date: 2024-01-04 16:45:25

N-nitrosoanabasine structure	Common Name	N-nitrosoanabasine
	CAS Number	37620-20-5	Molecular Weight	191.230
	Density	1.2±0.1 g/cm3	Boiling Point	380.2±35.0 °C at 760 mmHg
	Molecular Formula	C₁₀H₁₃N₃O	Melting Point	N/A
	MSDS	Chinese USA	Flash Point	183.8±25.9 °C
	Symbol	GHS06	Signal Word	Danger

Name	(r,s)-n-nitrosoanabasine
Synonym	More Synonyms

Density	1.2±0.1 g/cm3
Boiling Point	380.2±35.0 °C at 760 mmHg
Molecular Formula	C₁₀H₁₃N₃O
Molecular Weight	191.230
Flash Point	183.8±25.9 °C
Exact Mass	191.105865
PSA	45.56000
LogP	0.49
Vapour Pressure	0.0±0.8 mmHg at 25°C
Index of Refraction	1.625
Storage condition	-20°C Freezer

Symbol	GHS06
Signal Word	Danger
Hazard Statements	H301
Precautionary Statements	P301 + P310
Personal Protective Equipment	Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter
Hazard Codes	T
Risk Phrases	25
Safety Phrases	45
RIDADR	UN2810 6.1/PG 3
HS Code	2933990090

(±)-Anabasine

CAS#:13078-04-1

N-nitrosoanabasine

CAS#:37620-20-5

Literature: Chemische Berichte, , vol. 65, p. 1126,1128

Anabasine

CAS#:494-52-0

N-nitrosoanabasine

CAS#:37620-20-5

Literature: Chemische Berichte, , vol. 65, p. 1126,1128

Precursor 2
CAS#:13078-04-1 (±)-Anabasine CAS#:494-52-0 Anabasine
DownStream 0

HS Code	2933990090
Summary	2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Pancreatic endoplasmic reticulum kinase activation promotes medulloblastoma cell migration and invasion through induction of vascular endothelial growth factor A.

PLoS ONE 10(3) , e0120252, (2015)

Evidence is accumulating that activation of the pancreatic endoplasmic reticulum kinase (PERK) in response to endoplasmic reticulum (ER) stress adapts tumor cells to the tumor microenvironment and enh...

Physiologically based pharmacokinetic modeling to predict drug-drug interactions involving inhibitory metabolite: a case study of amiodarone.

Drug Metab. Dispos. 43(2) , 182-9, (2014)

Evaluation of drug-drug interaction (DDI) involving circulating inhibitory metabolites of perpetrator drugs has recently drawn more attention from regulatory agencies and pharmaceutical companies. Her...

Disparities in child mortality trends: what is the evidence from disadvantaged states in India? the case of Orissa and Madhya Pradesh.

Int J Equity Health 12 , 45, (2013)

The Millennium Development Goals prompted renewed international efforts to reduce under-five mortality and measure national progress. However, scant evidence exists about the distribution of child mor...

3-(1-Nitrosopiperidin-2-yl)pyridine

1-nitro-pyrene

Pyrene,1-nitro

Nitropyrene,Mono-,Di-,Tri-Tetra,isomers

3-Nitropyrene

nitropyrene

1-nitropyrne

3-(1-Nitroso-2-piperidinyl)pyridine

N-nitrosoanabasine

1-nitroso-anabasine

Pyridine, 3-(1-nitroso-2-piperidinyl)-

Nitrosoanabasin